Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura

Journal of the American Society of Nephrology

Volumn 10, Issue 6, 1999, Pages 1234-1241

  Galbusera, Miriam ^b   Benigni, Ariela ^a   Paris, Simona ^b   Ruggenenti, Piero ^b   Zoja, Carla ^b   Rossi, Chiara ^b   Remuzzi, Giuseppe ^b  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFECT; PROTEIN STRUCTURE; REMISSION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0033061320     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Remuzzi G, Ruggenenti P, Bertani T: Thrombotic microangiopathy. In: Renal Pathology, edited by Tischer CC, Brenner BM, Philadelphia, Lippincott, 1994, pp 1154-1184
2. Byrnes JJ, Khurana M: Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 297: 1386-1389, 1977
3. Ruggenenti P, Galbusera M, Plata Cornejo RP, Bellavita P, Remuzzi G: Thrombotic thrombocytopenic purpura: Evidence that infusion rather than removal of plasma induces remission of the disease. Am J Kidney Dis 21: 314-318, 1993
4. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 325: 393-397, 1991
5. Moake J, Chintagumpala M, Turner N, McPherson P, Nolasco L, Steuber C, Santiago-Borrero P, Horowitz M, Pehta J: Solvent/ detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura. Blood 84: 490-497, 1994
6. Asada Y, Sumiyoshi A, Hayashi T, Suzumiya J, Kaketani K: Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res 38: 469-479, 1985
7. Wagner DD: Cell biology of von Willebrand factor. Annu Rev Cell Biol 6: 217-246, 1990
8. Ruggeri ZM, Zimmerman TS: von Willebrand factor and von Willebrand disease. Blood 70: 895-904, 1987
9. Furlan M, Robles R, Lammle B: Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87: 4223-4234, 1996
10. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD: Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 78: 1456-1461, 1986
11. Moake JL: Haemolytic-uraemic syndrome: Basic science. Lancet 343: 393-397, 1994
12. Moake JL, McPherson PD: Abnormalities of von Willebrand factor multimers in thrombotic thombocytopenic purpura and the hemolytic-uremic syndrome. Am J Med 87: 9N-15N, 1989
13. Mannucci PM, Lombardi R, Lattuada A, Ruggenenti P, Viganò GL, Barbui T, Remuzzi G: Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Blood 74: 978-983, 1989
14. Remuzzi G, Ruggenenti P: The hemolytic uremic syndrome. Kidney Int 48: 2-19, 1995
15. Ruggenenti P, Remuzzi G: The pathophysiology and management of thrombotic thrombocytopenic purpura. Eur J Haematol 56: 191-207, 1996
16. Ruggenenti P, Remuzzi G: Treatment of thrombotic microangiopathy. J Nephrol 8: 255-272, 1995
17. Remuzzi G, Galbusera M, Salvadori M, Rizzoni G, Paris S, Ruggenenti P: Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma. Kidney Int 49: 282-286, 1996
18. Ruggeri ZM, Zimmerman TS: The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57: 1140-1143, 1981
19. Ciavarella G, Ciavarella N, Antoncecchi S, De Mattia D, Ranieri P, Dent J, Zimmerman TS, Ruggeri ZM: High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC). Blood 66: 1423-1429, 1985
20. Tsai HM, Sussman II, Nagel RL: Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 83: 2171-2179, 1994
21. Moore JC, Murphy WG, Kelton JG: Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: An explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Br J Haematol 74: 457-464, 1990
22. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D: Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307: 1432-1435, 1982
23. Rose PE, Enayat SM, Sunderland R, Short PE, Williams CE, Hill FG: Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome. Arch Dis Child 59: 1135-1140, 1984
24. Galbusera M, Ruggenenti P, Noris M, Burnouf-Radosevich M, Benigni A, Mannucci PM, Remuzzi G: Alpha1-antitrypsin therapy in a case of thrombotic thrombocytopenic purpura. Lancet 345: 224-225, 1995
25. Takahashi H, Hanano M, Wada K, Tatewaki W, Niwano H, Tsubouchi J, Nakano M, Nakamura T, Shibata A: Circulating thrombomodulin in thrombotic thrombocytopenic purpura. Am J Hematol 38: 174-177, 1991
26. Milford DV, Staten J, MacGreggor I, Dawes J, Taylor CM, Hill FG: Prognostic markers in diarrhoea-associated haemolytic-uraemic syndrome: Initial neutrophil count, human neutrophil elastase and von Willebrand factor antigen. Nephrol Dial Transplant 6: 232-237, 1991
27. Gralnick HR, Williams SB, McKeown LP, Krizek DM, Shafer BC, Rick ME: Platelet von Willebrand factor: Comparison with plasma von Willebrand factor. Thromb Res 38: 623-633, 1985
28. Wada H, Kaneko T, Ohiwa M, Tanigawa M, Tamaki S, Minami N, Takahashi H, Deguchi K, Nakano T, Shirakawa S: Plasma cytokine levels in thrombotic thrombocytopenic purpura. Am J Hematol 40: 167-172, 1992
29. Fitzpatrick MM, Shah V, Trompeter RS, Dillon MJ, Barratt TM: Interleukin-8 and polymorphoneutrophil leukocyte activation in hemolytic uremic syndrome of childhood. Kidney Int 42: 951-956, 1992
30. Moake JL: Thrombotic thrombocytopenic purpura. Thromb Haemostasis 74: 240-245, 1995
31. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lammle B: Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 89: 3097-3103, 1997
32. Furlan M, Robles R, Solenthaler M, Lammle B: Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood 91: 2839-2846, 1998
33. Murphy WG, Moore JC, Kelton JG: Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura. Blood 70: 1683-1687, 1987
34. Falanga A, Consonni R, Ruggenenti P, Barbui T: A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura. Br J Haematol 79: 474-480, 1991